Parkinson disease (PD) is the second most common neurodegenerative disorder, affecting>
1% of the population≥ 65 years of age and with a prevalence set to double by 2030. In …

Objective To update evidence‐based medicine recommendations for treating nonmotor
symptoms in Parkinson's disease (PD). Background The International Parkinson and …

Importance Parkinson disease is the second most common neurodegenerative disease
worldwide. Although no available therapies alter the underlying neurodegenerative process …

Dementia is one of the most common and important aspects of Parkinson's disease and has
consequences for patients and caregivers, and has health-related costs. Mild cognitive …

Background: Parkinson's disease (PD) is a neurodegenerative disorder with a prevalence
increasing with age. Oxidative stress and glutamate toxicity are involved in its …

Attention played a vital role in the historical development of the fi eld of psychology. Early
psychologists pondered the nature of attention and attempted to characterize its …

Alzheimer's disease (AD) and Parkinson's disease (PD) are the two most common
neurodegenerative disorders encountered in clinical practice. Whilst dementia has long …

While Parkinson's disease (PD) traditionally has been defined by its characteristic motor
hallmarks, non-motor features such as cognitive impairment and dementia are increasingly …

Cognitive impairment risk in Parkinson's disease increases with disease progression and
poses a significant burden to the patients, their families and society. There are no disease …

We examined the frequency of Parkinson disease with mild cognitive impairment (PD‐MCI)
and its subtypes and the accuracy of 3 cognitive scales for detecting PD‐MCI using the new …